PT
● MODULE 04 / 20
Adverse Reactions, Interactions & Safe Prescribing
Recognize preventable harm and build an individualized prescribing and monitoring plan.
Quick revision ↓ Medical Dictionary
FULL CHAPTER EXPLANATION
Deep Learning — Module 04
Read this section in sequence. It moves from drug targets to therapeutic effects, adverse reactions and safe use.
01
Classifying harm
A predictable dose-related adverse reaction often follows the known pharmacology, such as excessive bleeding with an anticoagulant. Other reactions are less predictable, including immune-mediated allergy. Side effect, allergy, overdose, medication error and treatment failure are different concepts. Record the actual reaction and timing instead of labeling every intolerance an allergy. Suspected serious reactions require clinical assessment and reporting through the relevant pharmacovigilance pathway; proof of causation is not required before a report.
02
Predicting interactions
Pharmacokinetic interactions alter exposure; pharmacodynamic interactions alter combined effect. Enzyme induction can reduce a susceptible active drug concentration, whereas enzyme inhibition may increase it. Chelation can reduce intestinal absorption of certain antibiotics. An anticoagulant plus an NSAID can increase bleeding through multiple mechanisms. A medication review must include over-the-counter and herbal products because a nonprescription label does not guarantee safety or absence of interactions.
03
Special populations
Children require age-appropriate formulations and weight-based calculations where indicated; they are not simply small adults. Older people often have altered renal function, multiple medicines and increased sensitivity to sedation or hypotension. Pregnancy and lactation require drug-specific assessment of timing, exposure and benefit versus risk. Kidney and liver disease may change elimination or protein binding. Avoid assuming a normal serum creatinine proves normal renal clearance in an older person with low muscle mass.
04
Rational prescribing
Define the clinical problem and therapeutic goal, compare suitable options, verify the choice for this patient, write an unambiguous prescription, explain the plan and monitor its result. Check indication, allergy, dose, route, duration, interactions and practical access. Prescriptions need patient and prescriber identifiers and clear instructions. Use a leading zero for amounts below one and avoid unnecessary trailing zeros. A medicine without a continuing indication should be reviewed for safe withdrawal rather than renewed automatically.
05
Monitoring and pharmacogenetics
Therapeutic drug monitoring is useful when concentrations relate to response or toxicity and clinical assessment alone is insufficient. Interpret results using sample timing, steady state, renal function and adherence. Genetic differences can affect metabolism or immune toxicity, but testing is drug- and context-specific. An abnormal result is a reason to investigate rather than blindly change the dose. Review benefits and harms at a planned time, document the decision and provide a route for the patient to report problems.
High-Yield Revision
- Ask what happened, when it happened and which medicines were actually taken.
- Choose a monitoring endpoint and review date when starting therapy.
- Reconcile prescription, nonprescription and herbal products.
Common Exam & Concept Pitfalls
- Do not call every gastrointestinal intolerance a drug allergy.
- A reference-range drug level does not overrule convincing toxicity.
Sources & Further Reading
Curriculum scope checked 23 September 2026. These original study notes summarize established principles; current institutional guidance and product information govern clinical use. Faculty review is pending.
RAHBAR study structure: target → drug action → therapeutic use → adverse effects → monitoring. Use institutional curriculum and faculty guidance for local sequencing, practical requirements and assessment specifications.